The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Open accessAbstract
TGR5 is a G protein-coupled receptor expressed in brown adipose tissue and muscle, where its activation by bile acids triggers an increase in energy expenditure and attenuates diet-induced obesity. Using a combination of pharmacological and genetic gain- and loss-of-function studies in vivo, we show here that TGR5 signaling induces intestinal glucagon-like peptide-1 (GLP-1) release, leading to improved liver and pancreatic function and enhanced glucose tolerance in obese mice. In addition, we show that the induction of GLP-1 release in enteroendocrine cells by 6alpha-ethyl-23(S)-methyl-cholic acid (EMCA, INT-777), a specific TGR5 agonist, is linked to an increase of the intracellular ATP/ADP ratio and a subsequent rise in intracellular calcium mobilization. Altogether, these data show that the TGR5 signaling pathway is critical in regulating intestinal GLP-1 secretion in vivo, and suggest that pharmacological targeting of TGR5 may constitute a promising incretin-based strategy for the treatment of diabesity and associated metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bacteria-derived secondary bile acids (lithocholic acid, deoxycholic acid) can activate the G-protein coupled bile acid receptor Gpbar1 receptor (TGR5) in L cells, promoting the peripheral release of GLP-1 and PYY (Katsuma et al., 2005;Thomas et al., 2009;Ullmer et al., 2013).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2009
Experimental — accuracy not yet measuredIn the citing paper
“Bile acids induce insulin secretion directly via the transmembrane bile acid receptor Takeda G protein–coupled receptor 5 (on β cells and indirectly via stimulation of l-cell derived GLP-1 and subsequent insulin release (110–112).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [112]
In the citing paper
“TGR5 is therefore a new and attractive target for treating obesity, since it can theoretically protect against obesity and its complications via two distinct and potentially synergistic mechanisms: increased energy expenditure and improved insulin sensitivity 148.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
In the citing paper
“Bile acids also increase energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This effect is dependent on induction of the type 2 iodothyronine deiodinase and is mediated by the binding of bile acids to a novel G-protein-coupled receptor TGR5 148.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
In the citing paper
“Bile acids also increase energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This effect is dependent on induction of the type 2 iodothyronine deiodinase and is mediated by the binding of bile acids to a novel G-protein-coupled receptor TGR5 148.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
In the citing paper
“One promising TGR5 agonist, INT-777, has already shown efficacy in vivo, increasing energy expenditure and reducing adiposity in mice with diet-induced obesity 148,149.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2004) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,580
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21025 · Cited by 1,425
Self-citationTargeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422 · cited 2×
“The complete absence of changes in the expression level of classical target genes of FXR in the liver, such as cholesterol 7a hydroxylase (CYP7A1) and bile salt export pump (BSEP) (Thomas et al., 2008), further confirmed the specificity of INT-777 toward TGR5 (Figure S6B).”
BackgroundSelf-citationIdentification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 974
Cited by
Sorted by citations
Items 301–400 of 999
Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids
Ferrebee, C. B., & Dawson, P. A. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.001 · Cited by 131
A Surgical Model in Male Obese Rats Uncovers Protective Effects of Bile Acids Post-Bariatric Surgery
Kohli, R., Setchell, K. D. R., Kirby, M., Myronovych, A., Ryan, K. K., Ibrahim, S. H., Berger, J., Smith, K., Toure, M. H., Woods, S. C., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2069 · Cited by 131
Miyazaki‐Anzai, S., Masuda, M., Levi, M., Keenan, A. L., & Miyazaki, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108270 · Cited by 132
Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids
Liu, C., Du, M., Xie, L., Wang, W.-Z., Chen, B., Yun, C., Sun, X., Luo, X., Jiang, Y., Wang, K., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01570-0 · Cited by 129
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Wu, T., Bound, M. J., Standfield, S., Gedulin, B. R., Jones, K. L., Horowitz, M., & Rayner, C. K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12043 · Cited by 124
Perspective: TGR5 (Gpbar-1) in liver physiology and disease
Keitel, V., & Häussinger, D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.03.008 · Cited by 129
Khan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 130
Kwon, J., Lee, C., Heo, S., Kim, B., & Hyun, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-84761-1 · Cited by 127
Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease
Xie, C., Huang, W., Young, R. L., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2021) · Nutrients · doi:10.3390/nu13041104 · Cited by 124
Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling
Wang, Q., Lin, H., Shen, C., Zhang, M., Wang, X., Yuan, M., Yuan, M., Jia, S., Cao, Z., Wu, C., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2274124 · Cited by 126
The gut microbiome in cardio-metabolic health
Hansen, T. H., Gøbel, R. J., Hansen, T. F., & Pedersen, O. B. (2015) · Genome Medicine · doi:10.1186/s13073-015-0157-z · Cited by 132
Liu, H., Pathak, P., Boehme, S., & Chiang, J. Y. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069807 · Cited by 125
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 132
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 128
Jain, A. K., Stoll, B., Burrin, D. G., Holst, J. J., & Moore, D. D. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00280.2011 · Cited by 123
Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
Brubaker, P. L. (2010) · Endocrinology · doi:10.1210/en.2010-0115 · Cited by 122
The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia
Okin, D. A., & Medzhitov, R. M. (2016) · Cell · doi:10.1016/j.cell.2016.02.023 · Cited by 126
Reich, M., Spomer, L., Klindt, C., Fuchs, K., Stindt, J., Deutschmann, K., Höhne, J., Liaskou, E., Hov, J. R., Karlsen, T. H., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.03.029 · Cited by 121
Self-citationImpact of air pollution on intestinal redox lipidome and microbiome
Feng, J., Cavallero, S., Hsiai, T. K., & Li, R. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.044 · Cited by 120
TGR5: A Novel Target for Weight Maintenance and Glucose Metabolism
Chen, X., Lou, G., Meng, Z., & Huang, W. (2011) · Experimental Diabetes Research · doi:10.1155/2011/853501 · Cited by 125
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
Sweeney, T. E., & Morton, J. M. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.016 · Cited by 126
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 125
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
Jadhav, K. S., Xu, Y., Xu, Y., Li, Y., Xu, J., Zhu, Y., Adorini, L., Lee, Y., Kasumov, T., Yin, L., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.005 · Cited by 124
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 131
Ding, L., Yang, Q., Zhang, E., Wang, Y., Sun, S., Yang, Y., Tong, T., Ju, Z., Jiang, L., Wang, X., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.038 · Cited by 120
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Jiao, T., Ma, Y., Guo, X., Ye, Y., & Xie, C. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00880-z · Cited by 122
A Role of the Bile Salt Receptor FXR in Atherosclerosis
Hageman, J., Herrema, H., Groen, A. K., & Kuipers, F. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.197897 · Cited by 122
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
Nagahashi, M., Yuza, K., Hirose, Y., Nakajima, M., Ramanathan, R., Hait, N. C., Hylemon, P. B., Zhou, H., Takabe, K., & Wakai, T. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r069286 · Cited by 118
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
Kimhofer, T., Fye, H. K. S., Taylor-Robinson, S. D., Thursz, M. R., & Holmes, E. C. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.38 · Cited by 117
Cariou, B., Chétiveaux, M., Zaïr, Y., Pouteau, E. B., Disse, E., Guyomarch, B., Laville, M., & Krempf, M. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-48 · Cited by 118
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
Tsuei, J., Chau, T., Mills, D. A., & Wan, Y. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538743 · Cited by 119
Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats
Hansen, C. F., Bueter, M., Theis, N., Lutz, T. A., Paulsen, S. J., Dalbøge, L. S., Vrang, N., & Jelsing, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065696 · Cited by 115
Deiodinases and the Metabolic Code for Thyroid Hormone Action
Russo, S. C., Salas-Lucia, F., & Bianco, A. C. (2021) · Endocrinology · doi:10.1210/endocr/bqab059 · Cited by 130
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
Du, L., Li, Q., Yi, H., Kuang, T., Tang, Y. P., & Fan, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112839 · Cited by 118
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 115
Bile acid metabolism and circadian rhythms
Yang, Y., & Zhang, J. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00152.2020 · Cited by 118
Metabolomics in diabetes, a review
Pallares-Méndez, R., Aguilar-Salinas, C. A., Cruz‐Bautista, I., & del Bosque‐Plata, L. (2016) · Annals of Medicine · doi:10.3109/07853890.2015.1137630 · Cited by 120
Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
渡辺, 光., Morimoto, K., Houten, S. M., Kaneko-Iwasaki, N., Sugizaki, T., Horai, Y., Mataki, C., Sato, H., Murahashi, K., Arita, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038286 · Cited by 113
Self-citationPathophysiological connections between gallstone disease, insulin resistance, and obesity
Cortés, V., Francisco Barrera, M., & Nervi, F. O. (2019) · Obesity Reviews · doi:10.1111/obr.12983 · Cited by 118
Protective and ameliorating effects of probiotics against diet-induced obesity: A review
Tang, C., Kong, L., Shan, M., Lu, Z., & Lu, Y. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110490 · Cited by 119
Ono, E., Inoue, J., Hashidume, T., Shimizu, M., & Sato, R. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.055 · Cited by 116
Sachdev, S., Wang, Q., Billington, C. J., Connett, J., Ahmed, L., Inabnet, W. B., Chua, S. C., Ikramuddin, S., & Körner, J. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1834-0 · Cited by 113
Gut microbial metabolite short-chain fatty acids and obesity
Li, X., Shimizu, Y., & Kimura, I. (2017) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.17-010 · Cited by 113
Morville, T. H., Sahl, R. E., Trammell, S. A. J., Svenningsen, J. S., Gillum, M. P., Helge, J. W., & Clemmensen, C. (2018) · JCI Insight · doi:10.1172/jci.insight.122737 · Cited by 112
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 114
Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract
Bunnett, N. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.271155 · Cited by 110
Bile acid signaling and liver regeneration
Fan, M., Wang, X., Xu, G., Yan, Q., & Huang, W. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.021 · Cited by 110
Mechanisms controlling hormone secretion in human gut and its relevance to metabolism
Martin, A. M., Sun, E. W. L., & Keating, D. J. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0399 · Cited by 117
Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
Naseer, M. I., Bibi, F., Al-Qahtani, M. H., Chaudhary, A., Azhar, E. I., Kamal, M. A., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109
Gut-brain communication and obesity: understanding functions of the vagus nerve
Berthoud, H., Albaugh, V. L., & Neuhuber, W. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143770 · Cited by 111
Microbiota–Host Transgenomic Metabolism, Bioactive Molecules from the Inside
Turroni, S., Brigidi, P., Cavalli, A., & Candela, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00244 · Cited by 111
Lithocholic acid phenocopies anti-ageing effects of calorie restriction
Qu, Q., Chen, Y., Wang, Y., Long, S., Wang, W., Yang, H.-Y., Li, M., Tian, X., Wei, X., Liu, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08329-5 · Cited by 123
Kemper, J. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.011 · Cited by 108
Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice
Kim, K. H., Choi, S., Zhou, Y., Kim, E. Y., Lee, J. M., Saha, P. K., Anakk, S., & Moore, D. D. (2017) · Hepatology · doi:10.1002/hep.29199 · Cited by 107
The Microbiota and the Gut–Brain Axis in Controlling Food Intake and Energy Homeostasis
Romaní‐Pérez, M., Bullich‐Vilarrubias, C., López‐Almela, I., Liébana-García, R., Olivares, M., & Sanz, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115830 · Cited by 117
Role of TGR5 (GPBAR1) in Liver Disease
Häussinger, D., & Keitel, V. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1669940 · Cited by 106
Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells
Goldberg, A. A., Titorenko, V. I., Beach, A., & Sanderson, J. T. (2013) · PeerJ · doi:10.7717/peerj.122 · Cited by 105
Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis
Song, Y., Xu, C., Shao, S., Liu, J., Wanjia, X., Xu, J., Qin, C., Li, C., Hu, B., Yi, S., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.006 · Cited by 106
Münzker, J., Haase, N., Till, A., Sucher, R., Haange, S., Nemetschke, L., Gnad, T., Jäger, E., Chen, J., Riede, S. J., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01264-5 · Cited by 109
The physiology underlying Roux-en-Y gastric bypass: a status report
Lutz, T. A., & Bueter, M. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00185.2014 · Cited by 111
Liu, J., Li, Y., Yang, P., Wan, J., Chang, Q., Wang, T. T. Y., Lu, W., Zhang, Y., Wang, Q., & Yu, L. L. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03382 · Cited by 105
Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion
Lu, V. B., Gribble, F. M., & Reimann, F. M. (2021) · Nutrients · doi:10.3390/nu13030883 · Cited by 111
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Simbrunner, B., Trauner, M., & Reiberger, T. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16602 · Cited by 108
Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor
Diep, T. A., Madsen, A. N., Holst, B., Kristiansen, M. M., Wellner, N., Hansen, S. H., & Hansen, H. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-166595 · Cited by 104
The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice
Sasaki, T., Kuboyama, A., Mita, M., Murata, S., Shimizu, M., Inoue, J., Mori, K., & Sato, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002733 · Cited by 109
Zuo, G., Zhang, T., Huang, L., Araujo, C., Peng, J., Travis, Z. D., Okada, T., Ocak, U., Zhang, G., Tang, J., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.002 · Cited by 103
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
Gillard, J., Clerbaux, L., Nachit, M., Sempoux, C. L., Staels, B., Bindels, L. B., Tailleux, A., & Leclercq, I. A. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100387 · Cited by 111
Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function
Brubaker, P. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170055 · Cited by 132
Faecal Microbiota Are Related to Insulin Sensitivity and Secretion in Overweight or Obese Adults
Naderpoor, N., Mousa, A., Gómez-Arango, L. F., Barrett, H. L., Nitert, M. D., & de Courten, B. V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040452 · Cited by 104
Physiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 105
Zhang, C., Fang, R., Lu, X., Zhang, Y., Yang, M., Su, Y., Jiang, Y., & Man, C. (2022) · Food & Function · doi:10.1039/d1fo04387k · Cited by 108
Zarrinpar, A., & Loomba, R. S. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 104
Is It Time to Use Probiotics to Prevent or Treat Obesity?
Brusaferro, A., Cozzali, R., Orabona, C., Biscarini, A., Farinelli, E., Cavalli, E., Grohmann, U., Principi, N., & Esposito, S. (2018) · Nutrients · doi:10.3390/nu10111613 · Cited by 106
Udayappan, S. D., Hartstra, A. V., Dallinga‐Thie, G. M., & Nieuwdorp, M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12293 · Cited by 104
Magotti, P., Bauer, I., Igarashi, M., Babagoli, M. A., Marotta, R., Piomelli, D., & Garau, G. (2015) · Structure · doi:10.1016/j.str.2014.12.018 · Cited by 100
Speck, M., Cho, Y. M., Asadi, A., Rubino, F., & Kieffer, T. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00422.2010 · Cited by 101
Suga, T., Yamaguchi, H., Sato, T., Maekawa, M., Goto, J., & Mano, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169719 · Cited by 107
Microbial Metabolites: Critical Regulators in NAFLD
Dai, X., Hou, H., Zhang, W., Liu, T., Li, Y., Wang, S., Wang, B., & Cao, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.567654 · Cited by 103
Critical roles of bile acids in regulating intestinal mucosal immune responses
Sun, R., Xu, C., Feng, B., Gao, X., & Liu, Z. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211018098 · Cited by 105
Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine
Abeltino, A., Hatem, D., Serantoni, C., Riente, A., Giulio, M. M. D., Spirito, M. D., Maio, F. D., & Maulucci, G. (2024) · Nutrients · doi:10.3390/nu16223806 · Cited by 121
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes
Chen, L., Yao, X., Young, A., McNulty, J. A., Anderson, D., Liu, Y., Nystrom, C., Croom, D. K., Ross, S. A., Collins, J. L., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2011 · Cited by 103
Wu, X. G., Lv, Y., Du, Y., Chen, F., Reed, M. N., Hu, M. Y., Suppiramaniam, V. D., Tang, S., & Hong, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.06.018 · Cited by 100
Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors
Keitel, V., Stindt, J., & Häussinger, D. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_230 · Cited by 98
The Gut-Liver Axis in Cholestatic Liver Diseases
Blesl, A., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13031018 · Cited by 102
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
Chiang, J. Y. L., Pathak, P., Liu, H., Donepudi, A. C., Ferrell, J. M., & Boehme, S. (2017) · Digestive Diseases · doi:10.1159/000450981 · Cited by 101
A review on gut microbiota: a central factor in the pathophysiology of obesity
Cunningham, A., Stephens, J. W., & Harris, D. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01491-z · Cited by 105
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota
Duszka, K. (2022) · Cells · doi:10.3390/cells11152337 · Cited by 101
D’Amore, C., Leva, F. S. D., Sepe, V., Renga, B., Gaudio, C. D., D’Auria, M. V., Zampella, A., Fiorucci, S., & Limongelli, V. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401873d · Cited by 96
Diabetes resolution and hyperinsulinaemia after metabolic Roux‐en‐Y gastric bypass
Ashrafian, H., Athanasiou, T., Li, J. V., Bueter, M., Ahmed, K., Nagpal, K., Holmes, E. C., Darzi, A. W., & Bloom, S. R. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00802.x · Cited by 102
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie, C., & Halegoua-DeMarzio, D. L. (2019) · Nutrients · doi:10.3390/nu11112837 · Cited by 99
Prinz, P., Hofmann, T., Ahnis, A., Elbelt, U., Goebel‐Stengel, M., Klapp, B. F., Rose, M., & Stengel, A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00199 · Cited by 100
Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice
Selwyn, F. P., Csanaky, I. L., Zhang, Y., & Klaassen, C. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065276 · Cited by 97
Vargas‐Castillo, A., Fuentes‐Romero, R., Rodríguez-López, L. A., Torres, N., & Tovar, A. R. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.10.002 · Cited by 101
Mochida, T., Hira, T., & Hara, H. (2010) · Endocrinology · doi:10.1210/en.2009-1510 · Cited by 95
The incretin hormone GLP‐1 and mechanisms underlying its secretion
Tian, L., & Jin, T. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12439 · Cited by 99
Molecular features of bile salt hydrolases and relevance in human health
Chand, D., Avinash, V. S., Yadav, Y., Pundle, A. V., Suresh, C. G., & Ramasamy, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.024 · Cited by 98
Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients
Yan, Y., Sha, Y.-H., Yao, G., Wang, S., Kong, F., Liu, H., Zhang, G., Zhang, H., Hu, C., & Zhang, X. (2016) · Medicine · doi:10.1097/md.0000000000003462 · Cited by 97
Metadata
- Authors
- Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., Pellicciari, R., Auwerx, J., & Schoonjans, K.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 10
- Issue
- 3
- Pages
- 167-177
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2739652
- OpenAlex
- W2081271380
- Cited by
- 1,885
- References
- 43
- Citations by year
- 2026: 143 · 2025: 100 · 2024: 153 · 2023: 112 · 2022: 135 · 2021: 141 · 2020: 148 · 2019: 113 · 2018: 124 · 2017: 126 · 2016: 106 · 2015: 108 · 2014: 87 · 2013: 91 · 2012: 69
- FWCI
- 47.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1415 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- European Commission
- Centre National de la Recherche Scientifique
- Australian Research Council
- National Institutes of Health
- Agence Nationale de la Recherche
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Keywords
- TGR5, glucose homeostasis, glucagon-like peptide-1, enteroendocrine cells, energy expenditure, diet-induced obesity, diabesity, ATP/ADP ratio, calcium mobilization, brown adipose tissue, pancreatic function, liver function, TGR5 agonists, INT-777, incretin-based therapy
- MeSH terms
- Adenosine Triphosphate, Animals, Bile Acids and Salts, Calcium, Cell Line, Cholic Acids, Cricetulus, Glucose, Cricetinae, Homeostasis, Humans, Insulin, Male, Mice, Inbred C57BL, Mice, Obese, Oxidative Phosphorylation, Signal Transduction, CHO Cells, Mice, Knockout, Enteroendocrine Cells, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
